- Overview
- Symptoms
- Causes & Risks
- Diagnosis
- Types
- Major Depressive Disorder
- Treatment
- Antidepressants
- Treatment-Resistant Depression (TRD)
- Living With
- Recovery & Relapse
- Complications
- Caregiving & Support
- Appointment Prep
- View Full Guide
Understanding Antidepressants and Depression


SSRIs: Boosting Serotonin Levels
Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed as the standard treatment for depression. They work by preventing the brain from reabsorbing serotonin, which helps improve mood. Common side effects include difficulty sleeping, headaches, and weight changes. Popular SSRIs include citalopram (Celexa) and fluoxetine (Prozac). Always talk with your doctor about potential side effects.

SNRIs: Dual Action Medications
Serotonin-norepinephrine reuptake inhibitors (SNRIs) work similarly to SSRIs but also increase norepinephrine levels, which can help elevate mood and energy. These medications are useful for people who don't respond well to SSRIs. Common SNRIs include desvenlafaxine (Pristiq) and duloxetine (Cymbalta). Be aware of side effects, such as nausea and dizziness.

TCAs: Early Antidepressants
Tricyclic antidepressants (TCAs) have been used since the 1950s. They are effective but often come with more side effects than newer medications. Common TCAs include amitriptyline (Elavil) and nortriptyline (Pamelor). These medications are typically considered when SSRIs and SNRIs are not effective.

MAOIs: Last Resort Options
Monoamine oxidase inhibitors (MAOIs) are rarely used today due to their many dietary restrictions and side effects. They work by inhibiting the enzyme monoamine oxidase, which increases levels of neurotransmitters in the brain. Examples include phenelzine (Nardil) and tranylcypromine (Parnate). Always discuss dietary restrictions with your doctor when taking MAOIs.

Important Considerations
Antidepressants can have various side effects and interactions, especially when combined with other medications. Always check your symptoms and stay in close contact with your health care provider. Understanding the side effects and interactions can help you make informed decisions about your treatment.
PHOTO CREDENTIALS
Slide 01 - Primestock Photography/Shutterstock
Slide 02 - Daniel Hoz/Shutterstock
Slide 03 - luchschenF/Shutterstock
Slide 04 - Miljan Zivkovic/Shutterstock
Slide 05 - Amnaj Khetsamtip/Shutterstock
SOURCES:
Andrew Leuchter, MD, professor of psychiatry; director, Laboratory of Brain, Behavior, and Pharmacology (LBBP); senior research scientist, Semel Institute for Neuroscience and Human Behavior and the Brain Research Institute, University of California, Los Angeles.
Agency for Health Care Research and Quality: "Medicines for treating depression -- A review of the research for adults."
National Institutes of Health: "Spotlight on SSRIs."
Family Doctor: "Depression -- Types of antidepressants."
Journal of the American Board of Family Medicine.
Centers for Medicare and Medicaid Services: "Your guide to Medicare Prescription Drug Coverage."
UpToDate: "Atypical antidepressants: Pharmacology, administration, and side effects."
BMJ Open: "Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study."
Cleveland Clinic: "Serotonin," "SSRIs (Selective Serotonin Reuptake Inhibitors)," "SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors)," "Linezolid tablets," "Tricyclic Antidepressants," "Antidepressants."
Canadian Medical Association Journal: "Antidepressant discontinuation syndrome."
Mayo Clinic: "Serotonin syndrome," "Selective serotonin reuptake inhibitors," "Serotonin and norepinephrine reuptake inhibitors (SNRIs)," "Monoamine oxidase inhibitors (MAOIs)," "MAOIs and diet: Is it necessary to restrict tyramine?" "Tricyclic antidepressants and tetracyclic antidepressants," "Atypical antidepressants," "Antidepressants: Another weapon against chronic pain."
Poison Control: "SNRI Antidepressants," "Antidepressants: Selective Serotonin Reuptake Inhibitors (SSRIs)."
Science Direct: "Sympathomimetic Amines."
StatPearls: "Selective Serotonin Reuptake Inhibitors," "Tricyclic Antidepressants," "Monoamine Oxidase Inhibitors (MAOI)," "Monoamine Oxidase Inhibitor Toxicity."
Therapeutic Advances in Psychopharmacology: "Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidance."
The University of British Columbia: "Genetic testing could greatly benefit patients with depression, save health system millions."